Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Oncology Reports
Published in: Current Oncology Reports 8/2021

01-08-2021 | COVID-19 | Cardio-oncology (EH Yang, Section Editor)

The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic

Authors: Jennifer M. Kwan, Mariana L. Henry, Briana Christophers, Kamala Tamirisa, Ritu Thamman, Diego Sadler, Niti R. Aggarwal, Richard Cheng, Purvi Parwani, Susan Dent, Roohi Ismail-Khan, Michael G. Fradley, Sherry-Ann Brown

Published in: Current Oncology Reports | Issue 8/2021

Login to get access

Abstract

Purpose of Review

To give an overview of the role of social media (SoMe) in cardio-oncology during the COVID-19 pandemic.

Recent Findings

SoMe has been critical in fostering education, outreach, awareness, collaboration, dissemination of information, and advocacy in cardio-oncology. This has become increasingly evident during the COVID-19 pandemic, during which SoMe has helped share best practices, community, and research focused on the impact of COVID-19 in cardiology and hematology/oncology, with cardio-oncology at the interface of these two subspecialty fields.

Summary

A strength of SoMe is the ability to amplify a message in real-time, globally, with minimal investment of resources. This has been particularly beneficial for the emerging field of cardio-hematology/cardio-oncology, a field focused on the interplay of cancer and cardiovascular disease. SoMe field especially during the COVID-19 pandemic. We illustrate how social media has supported innovation (including telemedicine), amplification of healthcare workers’ voice, and illumination of pre-existing and continued health disparities within the field of cardio-oncology during the pandemic.
Literature
1.
Mehta LS, Watson KE, Barac A, Beckie TM, Bittner V, Cruz-Flores S, et al. Cardiovascular disease and breast cancer: where these entities intersect: a scientific statement from the American Heart Association. Circulation. 2018;137(8):e30–66.PubMedPubMedCentralCrossRef
2.
Brown S-A, Daly RP, Duma N, Yang EH, Pemmaraju N, Parwani P, et al. Leveraging social media for cardio-oncology. Curr Treat Options in Oncol. 2020;21(10):1–19.CrossRef
3.
Parwani P, Choi AD, Lopez-Mattei J, Raza S, Chen T, Narang A, et al. Understanding social media: opportunities for cardiovascular medicine. J Am Coll Cardiol. 2019;73(9):1089–93.PubMedCrossRef
4.
Mandrola J, Futyma P. The role of social media in cardiology. Trends Cardiovasc Med. 2020;30(1):32–5.PubMedCrossRef
5.
Schumacher KR, Lee JM, Pasquali SK. Social media in paediatric heart disease: professional use and opportunities to improve cardiac care. Cardiol Young. 2015;25(8):1584–9.PubMedCrossRef
6.
Rosselló X, Stanbury M, Beeri R, Kirchhof P, Casadei B, Kotecha D. Digital learning and the future cardiologist. Eur Heart J. 2019;40(6):499–501.PubMedCrossRef
7.
8.
Cifu AS, Vandross AL, Prasad V. Case Reports in the Age of Twitter. Am J Med. 2019;132(10):e725–e6.PubMedCrossRef
9.
10.
Redfern J, Ingles J, Neubeck L, Johnston S, Semsarian C. Tweeting our way to cardiovascular health. J Am Coll Cardiol. 2013;61(15):1657–8.PubMedCrossRef
11.
Campbell L, Evans Y, Pumper M, Moreno MA. Social media use by physicians: a qualitative study of the new frontier of medicine. BMC Med Inform Decis Mak. 2016;16:91.PubMedPubMedCentralCrossRef
12.
Yeh RW. Academic cardiology and social media: navigating the wisdom and madness of the crowd. Circ Cardiovasc Qual Outcomes. 2018;11(4):e004736.PubMedCrossRef
13.
Brown S-A, Rhee J-W, Guha A, Rao VU. Innovation in precision cardio-oncology during the coronavirus pandemic and into a post-pandemic world. Front Cardiovasc Med. 2020;7:145.PubMedPubMedCentralCrossRef
14.
Eichstaedt JC, Smith RJ, Merchant RM, Ungar LH, Crutchley P, Preoţiuc-Pietro D, et al. Facebook language predicts depression in medical records. Proc Natl Acad Sci. 2018;115(44):11203.PubMedPubMedCentralCrossRef
15.
Reece AG, Danforth CM. Instagram photos reveal predictive markers of depression. EPJ Data Science. 2017;6(1):15.CrossRef
16.
Conley CC, Goyal NG, Brown SA. #CardioOncology: Twitter chat as a mechanism for increasing awareness of heart health for cancer patients. 2020;6:19–Cardiooncology.
17.
Aggarwal NR, Alasnag M, Mamas MA. Social media in the era of COVID-19. Open heart. 2020;7(2).
18.
Organization WH. Coronavirus disease (COVID-19) Situation Report - 162. 2020.
19.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.PubMedCrossRef
20.
Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan China. JAMA Cardiol. 2020;5(7):802–10.PubMedPubMedCentralCrossRef
21.
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811–8.PubMedCrossRef
22.
Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831–40.PubMedCrossRef
23.
Lee LY, Cazier JB, Starkey T, Turnbull C, Team UCCMP, Kerr R, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet. 2020.
24.
Lee LY, Cazier J-B, Starkey T, Briggs SE, Arnold R, Bisht V, et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. The Lancet Oncology. 2020;21(10):1309–16.PubMedPubMedCentralCrossRef
25.
Dai M, Liu D, Liu M, Zhou F, Li G, Chen Z, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer discovery. 2020;10(6):783–91.PubMedPubMedCentralCrossRef
26.
Navi BB, Reiner AS, Kamel H, Iadecola C, Okin PM, Elkind MSV, et al. Risk of arterial thromboembolism in patients with cancer. J Am Coll Cardiol. 2017;70(8):926–38.PubMedPubMedCentralCrossRef
27.
28.
Drobni ZD, Alvi RM, Taron J, Zafar A, Murphy SP, Rambarat PK, et al. Association between immune checkpoint inhibitors with cardiovascular events and atherosclerotic plaque. Circulation. 2020;142(24):2299–311.PubMedCrossRef
29.
30.
Zitelny E, Newman N, Zhao D. STEMI during the COVID-19 pandemic-an evaluation of incidence: Elsevier; 2020.
31.
Lwin MO, Lu J, Sheldenkar A, Schulz PJ, Shin W, Gupta R, et al. Global sentiments surrounding the COVID-19 pandemic on Twitter: analysis of Twitter trends. JMIR Public Health Surveill. 2020;6(2):e19447.PubMedPubMedCentralCrossRef
32.
Chen E, Lerman K, Ferrara E. Tracking social media discourse about the COVID-19 pandemic: development of a public coronavirus Twitter data set. JMIR Public Health Surveill. 2020;6(2):e19273.PubMedPubMedCentralCrossRef
33.
Bhagavathula AS, Aldhaleei WA, Rahmani J, Mahabadi MA, Bandari DK. Knowledge and perceptions of COVID-19 among health care workers: cross-sectional study. JMIR Public Health Surveill. 2020;6(2):e19160.PubMedPubMedCentralCrossRef
34.
Limaye RJ, Sauer M, Ali J, Bernstein J, Wahl B, Barnhill A, et al. Building trust while influencing online COVID-19 content in the social media world. The Lancet Digital Health. 2020;2(6):e277–e8.PubMedPubMedCentralCrossRef
35.
Basch CE, Basch CH, Hillyer GC, Jaime C. The role of YouTube and the entertainment industry in saving lives by educating and mobilizing the public to adopt behaviors for community mitigation of COVID-19: successive sampling design study. JMIR Public Health Surveill. 2020;6(2):e19145.PubMedPubMedCentralCrossRef
36.
Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020.
37.
38.
39.
Nayak A, Islam SJ, Mehta A, Ko Y-A, Patel SA, Goyal A, et al. Impact of social vulnerability on COVID-19 incidence and outcomes in the United States. medRxiv. 2020.
40.
Rodriguez JA, Clark CR, Bates DW. Digital health equity as a necessity in the 21st century cures act era. JAMA. 2020.
41.
Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, et al. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic: bridging or opening the digital divide? Circulation. 2020.
42.
Parikh A, Kumar AA, Jahangir E. Cardio-Oncology Care in the Time of COVID-19 and the Role of Telehealth. JACC: CardioOncology. 2020;2(2):356–8.PubMed
43.
Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, et al. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: an International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin. 2020.
44.
45.
46.
Tamirisa K. Impact of COVID-19 pandemic on the mental well-being of electrophysiology providers survey <div aria-label="Important according to Google magic." class="pG" data-tooltip-align="b,l" data-tooltip-contained="true" data-tooltip-delay="1500" id=":2jj" role="img" style="font-size: 0px; padding: 0px; position: relative; width: 20px; height: 20px; cursor: pointer; align-items: center; display: inline-block; justify-content: center; margin: 0px 8px 0px 0px;"> 2020 [Available from: https://​www.​surveymonkey.​com/​r/​XLZVGFP.
47.
Jain MK, Cheung VG, Utz PJ, Kobilka BK, Yamada T, Lefkowitz R. Saving the endangered physician-scientist—a plan for accelerating medical breakthroughs. N Engl J Med. 2019;381(5):399–402.PubMedCrossRef
48.
49.
50.
51.
52.
53.
54.
Chan TM, Stukus D, Leppink J, Duque L, Bigham BL, Mehta N, et al. Social media and the 21st-century scholar: how you can harness social media to amplify your career. J Am Coll Radiol. 2018;15(1):142–8.PubMedCrossRef
55.
Cabrera D, Vartabedian BS, Spinner RJ, Jordan BL, Aase LA, Timimi FK. More than likes and tweets: creating social media portfolios for academic promotion and tenure. Journal of graduate medical education. 2017;9(4):421–5.PubMedPubMedCentralCrossRef
56.
Cabrera D, Roy D, Chisolm MS. Social media scholarship and alternative metrics for academic promotion and tenure. J Am Coll Radiol. 2018;15(1):135–41.PubMedCrossRef
57.
Sherbino J, Arora VM, Van Melle E, Rogers R, Frank JR, Holmboe ES. Criteria for social media-based scholarship in health professions education. Postgrad Med J. 2015;91(1080):551–5.PubMedCrossRef
58.
Carpenter CR, Cone DC, Sarli CC. Using publication metrics to highlight academic productivity and research impact. Acad Emerg Med. 2014;21(10):1160–72.PubMedPubMedCentralCrossRef
59.
Buckarma EH, Thiels CA, Gas BL, Cabrera D, Bingener-Casey J, Farley DR. Influence of social media on the dissemination of a traditional surgical research article. J Surg Educ. 2017;74(1):79–83.PubMedCrossRef
60.
Eysenbach G. Can tweets predict citations? Metrics of social impact based on Twitter and correlation with traditional metrics of scientific impact. J Med Internet Res. 2011;13(4):e123.PubMedPubMedCentralCrossRef
61.
Smith ZL, Chiang AL, Bowman D, Wallace MB. Longitudinal relationship between social media activity and article citations in the journal Gastrointestinal Endoscopy. Gastrointest Endosc. 2019;90(1):77–83.PubMedCrossRef
62.
Widmer RJ, Mandrekar J, Ward A, Aase LA, Lanier WL, Timimi FK, et al. Effect of promotion via social media on access of articles in an academic medical journal: a randomized controlled trial. Academic Medicine. 2019;94(10).
63.
Pemmaraju N, Mesa RA, Majhail NS, Thompson MA, editors. The use and impact of Twitter at medical conferences: best practices and Twitter etiquette. Seminars in hematology; 2017: Elsevier.
64.
Pemmaraju N, Thompson MA, Mesa RA, Desai T. Analysis of the use and impact of Twitter during American Society of Clinical Oncology annual meetings from 2011 to 2016: focus on advanced metrics and user trends. Journal of oncology practice. 2017;13(7):e623–e31.PubMedPubMedCentralCrossRef
65.
Gorodeski EZ. Make your mark at medical meetings with social media 2018 MEDPAGE Today 2018
66.
Soreide K, Mackenzie G, Polom K, Lorenzon L, Mohan H, Mayol J. Tweeting the meeting: quantitative and qualitative twitter activity during the 38th ESSO conference. Eur J Surg Oncol. 2019;45(2):284–9.PubMedCrossRef
67.
Hudson S, Mackenzie G. ‘Not your daughter’s Facebook’: Twitter use at the European Society of Cardiology Conference 2018. Heart. 2019;105(2):169–70.PubMedCrossRef
68.
Tanoue MT, Chatterjee D, Nguyen HL, Sekimura T, West BH, Elashoff D, et al. Tweeting the meeting: rapid growth in the use of social media at major cardiovascular scientific sessions from 2014 to 2016. Circulation: Cardiovascular Quality and Outcomes. 2018;11(11):e005018.
69.
Sadler D. Cardio-Oncology International Collaborative Network survey. 2020.
70.
Diego Sadler JMD, Joerg Herrmann, Anita Arnold, Arjun K. Ghosh, Husam Abdel-Qadir, Eric H. Yang, Sebastian SZmit, Nausheen Akhter, Monika Leja, Carolina Maria Pinto Domingues Carvalho Silva, Jayant Raikhelkar, Sherry-Ann Brown, Rupal O'Quinn, Franck Thuny, Rohit Moudgil, Luis M. Raez, Tochukwu Okwuosa, Andres Daniele, Brenton Bauer, Lavanya Kondapalli, Roohi Ismail-Khan, Jorge Lax, Anne Blaes, Zeina Nahleh, Leah Elson, Lauren Baldassarre, Vlad Zaha, Vijay Rao, Daniel Sierra Lara, Kerry Skurka, Susan Dent. The COVID-19 Pandemic Impact on Cardio-Oncology: Results From the COVID-19 International Collaborative Network Survey. Cardio-oncology BMC. 2020;Preprint.
71.
Hoehn RS, Zureikat AH. Cancer disparities in the COVID-19 era. J Surg Oncol. 2020.
72.
73.
Levine RL. Cancer did not stay home for COVID-19. American Association for the Advancement of Science; 2020.CrossRef
74.
75.
Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, et al. Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020;371:m4087.PubMedCrossRef
76.
77.
Dickman SL, Himmelstein DU, Woolhandler S. Inequality and the health-care system in the USA. Lancet. 2017;389(10077):1431–41.PubMedCrossRef
78.
Wilson JB, Jackson LR II, Ugowe FE, Jones T, Yankey GS Jr, Marts C, et al. Racial and ethnic differences in treatment and outcomes of severe aortic stenosis: a review. J Am Coll Cardiol Intv. 2020;13(2):149–56.CrossRef
79.
Williams DR, Jackson PB. Social sources of racial disparities in health. Health Aff. 2005;24(2):325–34.CrossRef
80.
Forde AT, Crookes DM, Suglia SF, Demmer RT. The weathering hypothesis as an explanation for racial disparities in health: a systematic review. Ann Epidemiol. 2019;33:1–18. e3.PubMedCrossRef
81.
82.
Chowkwanyun M, Reed AL Jr. Racial health disparities and Covid-19—caution and context. N Engl J Med. 2020.
83.
van Dorn A, Cooney RE, Sabin ML. COVID-19 exacerbating inequalities in the US. Lancet (London, England). 2020;395(10232):1243.
84.
85.
86.
Haynes N, Cooper LA, Albert MA. Cardiologists AoB. At the heart of the matter: unmasking and addressing the toll of COVID-19 on diverse populations. Circulation. 2020;142(2):105–7.PubMedCrossRef
87.
88.
89.
90.
91.
92.
Househ M, Borycki E, Kushniruk A. Empowering patients through social media: the benefits and challenges. Health informatics journal. 2014;20(1):50–8.PubMedCrossRef
93.
Hawkins CM, DeLaO AJ, Hung C. Social media and the patient experience. J Am Coll Radiol. 2016;13(12):1615–21.PubMedCrossRef
94.
95.
Chung RY-N, Dong D, Li MM. Socioeconomic gradient in health and the covid-19 outbreak. Bmj. 2020;369.
96.
Yancy CW. COVID-19 and African Americans. Jama. 2020.
97.
Bommakanti KK, Smith LL, Liu L, Do D, Cuevas-Mota J, Collins K, et al. Requiring smartphone ownership for mHealth interventions: who could be left out? BMC Public Health. 2020;20(1):81.PubMedPubMedCentralCrossRef
98.
Chen IY, Joshi S, Ghassemi M. Treating health disparities with artificial intelligence. Nat Med. 2020;26(1):16–7.PubMedCrossRef
99.
Hardeman AN, Kahn MJ. Technological innovation in healthcare: disrupting old systems to create more value for African American patients in academic medical centers. J Natl Med Assoc. 2020;112(3):289–93.PubMed
100.
Breathett KK, Knapp SM, Wightman P, Desai A, Mazimba S, Calhoun E, et al. Is the affordable care act medicaid expansion linked to change in rate of ventricular assist device implantation for Blacks and Whites? Circ Heart Fail. 2020;13(4):e006544.PubMedPubMedCentralCrossRef
101.
Turvey CL, Klein DM, Nazi KM, Haidary ST, Bouhaddou O, Hsing N, et al. Racial differences in patient consent policy preferences for electronic health information exchange. J Am Med Inform Assoc. 2020;27(5):717–25.PubMedPubMedCentralCrossRef
102.
Kang JY, Kwon J, Sohn CH, Kim YJ, Lim HW, Lee SJ, et al. Big data-driven approach for health inequalities in foreign patients with injuries visiting emergency rooms. Healthc Inform Res. 2020;26(1):34–41.PubMedPubMedCentralCrossRef
103.
Noseworthy PA, Attia ZI, Brewer LC, Hayes SN, Yao X, Kapa S, et al. Assessing and mitigating bias in medical artificial intelligence: the effects of race and ethnicity on a deep learning model for ECG analysis. Circ Arrhythm Electrophysiol. 2020;13(3):e007988.PubMedPubMedCentralCrossRef
104.
McKendry RA, Rees G, Cox IJ, Johnson A, Edelstein M, Eland A, et al. Share mobile and social-media data to curb COVID-19. Nature. 2020;580(7801):29.PubMedCrossRef
105.
Thamman R, Gulati M, Narang A, Utengen A, Mamas MA, Bhatt DL. Twitter-based learning for continuing medical education?: A new perspective for a paradigm shift in medical education, accelerated by COVID-19. European Heart Journal. 2020.
Metadata
Title
The Role and Impact of Social Media in Cardio-oncology During the COVID-19 Pandemic
Authors
Jennifer M. Kwan
Mariana L. Henry
Briana Christophers
Kamala Tamirisa
Ritu Thamman
Diego Sadler
Niti R. Aggarwal
Richard Cheng
Purvi Parwani
Susan Dent
Roohi Ismail-Khan
Michael G. Fradley
Sherry-Ann Brown
Publication date
01-08-2021
Publisher
Springer US
Published in
Current Oncology Reports / Issue 8/2021
Print ISSN: 1523-3790
Electronic ISSN: 1534-6269
DOI
https://doi.org/10.1007/s11912-021-01081-3

Other articles of this Issue 8/2021

Current Oncology Reports 8/2021 Go to the issue

Leukemia (A Aguayo, Section Editor)

Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia

Correction

Correction to: Rare Adverse Events with Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors: Justification and Rationale for a Systematic Review

Palliative Medicine (A Jatoi, Section Editor)

Navigating the Cancer Screening Decision for Patients with Dementia

Immuno-oncology (RM Bukowski and JH Finke, Section Editors)

Immunology of Lynch Syndrome

Palliative Medicine (A Jatoi, Section Editor)

Management of Intractable Symptoms in Oncologic Care

Gynecologic Cancers (J Brown and RW Naumann, Section Editors)

Progress in Gynecologic Cancers with Antibody Drug Conjugates
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits